| 29650534 |
Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer
Yoda, S,
Lin, JJ,
Lawrence, MS,
Burke, BJ,
Friboulet, L,
Langenbucher, A,
Dardaei, L,
Prutisto-Chang, K,
Dagogo-Jack, I,
Timofeevski, S,
Hubbeling, H,
Gainor, JF,
Ferris, LA,
Riley, AK,
Kattermann, KE,
Timonina, D,
Heist, RS,
Iafrate, AJ,
Benes, CH,
Lennerz, JK,
Mino-Kenudson, M,
Engelman, JA,
Johnson, TW,
Hata, AN,
Shaw, AT
|
Cancer Discov |
2018 |